Latest News in the pharma Industry

Dechra receives FDA approval for first US generic entrant antibiotic

11 Sep 2016

Is the first registration Dechra has achieved through Putney's development pipeline since it acquired the US-based business

Orphan Drug Designation granted to nintedanib for treatment of systemic sclerosis

9 Sep 2016

Designation also includes the associated interstitial lung disease.

Lilly and AstraZeneca receive FDA Fast Track designation for AZD3293

22 Aug 2016

AZD3293 is an investigational treatment for early Alzheimer's disease

FDA pproves Pfizer's Troxyca ER Capsules CII with abuse-deterrent properties for the management of pain

21 Aug 2016

Indian FDA approves Innovus Pharma's Zestra, Zestra Glide, EjectDelay and Sensum+

21 Aug 2016

Products now approved in seven countries.

Portola Pharmaceuticals announces validation of MAA by EMA for IndexXa a Factor Xa inhibitoraAntidote

21 Aug 2016

EMA's CHMP to begin centralized review procedure.

Portola Pharmaceuticals receives CRL for BLA for AndexXa

18 Aug 2016

Agency request additional information primarily related to manufacturing.

FDA issues import alert for all drugs produced by Laxachem Organics in India

17 Aug 2016

Decision taken after company refuses to allow FDA facility inspection.

Merck announces FDA filing acceptance of NDA for MK-1293, an investigational follow-on biologic insulin glargine

8 Aug 2016

Marketing Authorization Application to the EMA currently under review.

FDA approves Merck’s Keytruda for patients with recurrent or metastatic HNSCC

7 Aug 2016

New treatment option for patients with with disease progression on or after platinum-containing chemotherapy.

FDA approves first generic version of influenza drug

7 Aug 2016

Natco receives approval for generic Tamiflu.

FDA approves Flonase Sensimist Allergy Relief

4 Aug 2016

Another Rx-to-OTC Switch from GSK Consumer Healthcare to help allergy sufferers find more complete relief.